145 related articles for article (PubMed ID: 12344723)
1. Lifestyle changes most often suggested for weight complaints. Special report: annual pill survey.
Contracept Technol Update; 1992 Oct; 13(10):154-6. PubMed ID: 12344723
[TBL] [Abstract][Full Text] [Related]
2. Experts debate pill switching to combat noncompliance. Special report: annual pill survey.
Contracept Technol Update; 1992 Oct; 13(10):149-53. PubMed ID: 12344722
[TBL] [Abstract][Full Text] [Related]
3. Use multiple strategies to manage common pill side effects.
Contracept Technol Update; 1988 Jul; 9(7):77-81. PubMed ID: 12281576
[TBL] [Abstract][Full Text] [Related]
4. Ask the experts: progestin-only contraceptives.
Hatcher RA; Schnare S
Contracept Technol Update; 1993 Jul; 14(7):114-5. PubMed ID: 12286999
[TBL] [Abstract][Full Text] [Related]
5. Pill won't budge from no. 1 spot: half of women leave exams with OCs.
Contracept Technol Update; 2000 Sep; 21(9):101-4. PubMed ID: 12296239
[TBL] [Abstract][Full Text] [Related]
6. Experts recommend ways to combat noncompliance. Special report: annual pill survey.
Contracept Technol Update; 1992 Oct; 13(10):156-8. PubMed ID: 12344724
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough bleeding number one problem with OC use.
Contracept Technol Update; 1991 Dec; 12(12):185-90. PubMed ID: 12285219
[TBL] [Abstract][Full Text] [Related]
8. Pills remain the top choice among reversible contraceptive options.
Contracept Technol Update; 1999 Sep; 20(9):97-101. PubMed ID: 12290380
[TBL] [Abstract][Full Text] [Related]
9. Approaches vary in managing the over-40 pill patient.
Contracept Technol Update; 1988 Sep; 9(9):105-7. PubMed ID: 12342192
[TBL] [Abstract][Full Text] [Related]
10. Most providers comfortable giving OCs to women over age 40. Special report: annual pill survey.
Contracept Technol Update; 1992 Oct; 13(10):158-9. PubMed ID: 12344725
[TBL] [Abstract][Full Text] [Related]
11. No over-the-counter OCs, say family planners.
Contracept Technol Update; 1998 Oct; 19(10):128. PubMed ID: 12321843
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives hold top position as leading choice for women.
Contracept Technol Update; 1997 Nov; 18(11):133-6. PubMed ID: 12292767
[TBL] [Abstract][Full Text] [Related]
13. Birth control over 30.
Asnes M
Work Woman; 1994 Jul; ():68-70, 72, 84. PubMed ID: 12291485
[TBL] [Abstract][Full Text] [Related]
14. How to use OCs? Readers offer insights.
Contracept Technol Update; 1999 Sep; 20(9):105-6. PubMed ID: 12290377
[TBL] [Abstract][Full Text] [Related]
15. Pill power: oral contraceptives hold top spot in family planning arsenal.
Contracept Technol Update; 1998 Oct; 19(10):125-7. PubMed ID: 12321842
[TBL] [Abstract][Full Text] [Related]
16. Teens and Depo-Provera: a good match?
Contracept Technol Update; 1995 Jul; 16(7):86-8. PubMed ID: 12346507
[TBL] [Abstract][Full Text] [Related]
17. FDA panel examines link between breast cancer, pill, says more research needed.
Wash Memo Alan Guttmacher Inst; 1989 Jan; ():3-4. PubMed ID: 12283353
[TBL] [Abstract][Full Text] [Related]
18. Examine use of low- and lower-dose OCs.
Contracept Technol Update; 2000 Jun; 21(6):72-3. PubMed ID: 12295925
[TBL] [Abstract][Full Text] [Related]
19. U.S. survey confirms pill, liver tumor link.
Int Fam Plann Dig; 1977 Sep; 3(3):15. PubMed ID: 12259974
[TBL] [Abstract][Full Text] [Related]
20. Consider prescribing OCs for perimenopause use.
Contracept Technol Update; 2000 Mar; 21(3):31-3. PubMed ID: 12349548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
